isograce

Video is generating, please wait!

Follow your doctors instructions for the dose and duration of Isograce 5mg Tablet Take it with food at the same time each day to avoid missing a dose It may take a few weeks to see improvements so continue using it regularly for maximum benefit Do not exceed the prescribed dosage or apply it more frequently as it will not speed up the process and may increase side effects The most common side effects include dry skin rash and increased liver enzymes These side effects are usually not severe and tend to go away as you adjust to the cream However if they persist or bother you inform your doctor They may recommend applying smaller amounts or using it less frequently Serious side effects are rare Isograce 5mg Tablet can make you more sensitive to sunlight so limit sun exposure if possible Stay hydrated and use a moisturizer to prevent dryness of the mouth lips and eyes It can also make your skin more fragile so avoid waxing hair removal or laser treatments while using this medication If you are pregnant or planning to become pregnant consult your doctor as this medicine may cause birth defects

Available in 4 variations

Isograce 5mg Tablet

Isotretinoin (5mg)

strip of 10 tablets

MRP : ₹90

Isograce 20mg Capsule 10s

Isotretinoin (20mg)

strip of 10 capsules

MRP : ₹175

Isograce 10mg Tablet 10s

Isotretinoin (10mg)

strip of 10 tablets

MRP : ₹130

Isograce 30mg Tablet

Isotretinoin (30mg)

strip of 10 tablets

MRP : ₹250

Related Faqs

What are the long-term side effects of Acutret?

The recommended duration of Acutret treatment typically spans over 15 to 20 weeks and as such the potential longterm implications of low doses have not yet been extensively researched Nonetheless it is worth noting that Acutret treatment could potentially impact bone mineral density Certain patients may experience a decrease in bone mineral density consequently increasing their susceptibility to conditions like osteoporosis or fractures Therefore it is essential for both patients and healthcare providers to be aware of these potential effects and to monitor the bone health of individuals undergoing Acutret treatment especially over extended periods By closely monitoring and addressing any negative impact on bone mineral density healthcare professionals can minimize the risk of longterm complications and ensure the overall wellbeing of patients Further research is required to comprehensively understand the extent of the effects of low doses of Acutret on bone health ensuring more informed decisionmaking for both medical practitioners and patients

Can Isopil cause cancer?

There have been no recorded cases of Isopil being linked to the development of cancer On the contrary this medication has shown potential benefits in treating certain types of head skin and neck cancers Its therapeutic properties make it a valuable option for patients struggling with these particular forms of cancer Isopil has undergone rigorous testing and scrutiny to ensure its safety and effectiveness Medical professionals closely monitor patients using Isopil to ensure they receive optimal care and any potential side effects are promptly addressed It is important to remember that each individuals response to medication can vary so it is crucial to consult with a healthcare provider to determine the most suitable treatment option for specific cancer types Rest assured Isopil remains a valuable tool in the fight against cancer and continues to provide hope and relief for numerous patients

Why is Zenitoin so dangerous during pregnancy?

In the event of pregnancy coinciding with Zenitoin treatment there is a significantly heightened possibility of the newborn being afflicted by profound congenital abnormalities These potential birth defects pose a grave concern and warrant diligent attention The unique composition of Zenitoin along with its potential impacts on fetal development underscores the utmost importance of carefully considering the risks involved in continuing treatment during pregnancy It is crucial to acknowledge that the momentous decision of whether to proceed with Zenitoin therapy while pregnant must be made in consultation with a knowledgeable healthcare professional The potential risks and benefits of maintaining the medication regimen need to be thoroughly evaluated and weighed against each other This thorough assessment should take into account the specific circumstances of the individual and consider alternative treatment options if available By no means should the severity of these birth defects be underestimated Considering the gravity of the situation it becomes vital for prospective parents to engage in proactive family planning discussions with their healthcare provider to ensure the most optimal outcome for both the mother and the unborn child Open communication and full disclosure of medical history are paramount in guiding these decisions and enabling healthcare professionals to provide the most appropriate and tailored guidance In conclusion if pregnancy coincides with Zenitoin treatment it is essential to be aware of the markedly increased risk of severe birth defects A thorough evaluation of the risks and benefits in consultation with a healthcare professional is crucial to guide decisionmaking and ensure the wellbeing of both mother and child